利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

39 条记录 (耗时 0.029 秒)

    Pancreatic polypeptide family motifs and polypeptides comprising the same
    13.
    发明授权
    Pancreatic polypeptide family motifs and polypeptides comprising the same 失效
    胰多肽家族基序和包含其的多肽

    公开(公告)号：US08603969B2

    公开(公告)日：2013-12-10

    申请号：US11055098

    申请日：2005-02-11

    申请人： Odile Esther Levy ,  Carolyn M. Jodka ,  Soumitra S. Ghosh ,  David G. Parkes ,  Richard A. Pittner ,  Lawrence J. D'Souza ,  John S. Ahn ,  Kathryn S. Prickett

    发明人： Odile Esther Levy ,  Carolyn M. Jodka ,  Soumitra S. Ghosh ,  David G. Parkes ,  Richard A. Pittner ,  Lawrence J. D'Souza ,  John S. Ahn ,  Kathryn S. Prickett

    IPC分类号： A61K38/22

    CPC分类号： C07K14/575 ,  A61K38/00 ,  C07K14/475

    摘要： The present invention relates to novel Pancreatic Polypeptide Family (“PPF”) polypeptides. The PPF polypeptides of the invention generally include at least two PPF motif, have at least 50% sequence identity to PYY (3-36) over its length and will generally retain, at least in part, a biological activity of a PP, PYY or NPY. Preferred PPF polypeptides of the invention are those having a potency in one of the assays described herein (preferably food intake, gastric emptying, pancreatic secretion, or weight reduction assays) which is greater than the potency of PP, NPY, PYY, or PYY(3-36) in that same assay. In one aspect, the PPF polypeptides of the invention include novel PYY analog polypeptides. In another aspect, the PPF polypeptides of the invention include PPF chimeric polypeptides including a fragment of a PP family polypeptide linked to a second PP family polypeptide, wherein each of the first and second fragments includes a PPF motif. Methods of using the PPF polypeptides of the invention, and pharmaceutical compositions including the PPF polypeptides of the invention are also disclosed.

    摘要翻译： 本发明涉及新型胰腺多肽家族（“PPF”）多肽。 本发明的PPF多肽通常包括至少两个PPF基序，其长度与PYY（3-36）具有至少50％的序列同一性，并且通常至少部分地保留PP，PYY的生物学活性或 NPY。 本发明优选的PPF多肽是在本文所述测定之一（优选食物摄取，胃排空，胰腺分泌或重量减轻试验）中具有效力的那些，其大于PP，NPY，PYY或PYY的效力（ 3-36）。 一方面，本发明的PPF多肽包括新的PYY类似物多肽。 在另一方面，本发明的PPF多肽包括PPF嵌合多肽，其包括与第二PP家族多肽连接的PP家族多肽的片段，其中第一和第二片段中的每一个包括PPF基序。 还公开了使用本发明的PPF多肽的方法和包括本发明的PPF多肽的药物组合物。

    Anti-diabetic peptides
    16.
    发明授权
    Anti-diabetic peptides 有权
    抗糖尿病肽

    公开(公告)号：US6087334A

    公开(公告)日：2000-07-11

    申请号：US138056

    申请日：1998-08-21

    申请人： Nigel Robert Arnold Beeley ,  Kathryn S. Prickett

    发明人： Nigel Robert Arnold Beeley ,  Kathryn S. Prickett

    IPC分类号： A61K38/04 ,  A61K38/00 ,  A61P1/00 ,  A61P3/10 ,  C07K7/08 ,  C07K14/00 ,  C07K14/575 ,  A61K39/00 ,  C07K5/00 ,  C07K7/00

    CPC分类号： C07K14/575 ,  A61K38/00

    摘要： Compounds of formula I which act as amylin agonists with respect to certain desired amylin activities and as calcitonin agonists with respect to certain desired calcitonin activities are provided. Such compounds are useful in treating disturbances in fuel metabolism in mammals, including, but not limited to diabetes mellitus, including Type I diabetes and Type II diabetes. The present invention also relates to methods of treating Type I diabetes, treating Type II diabetes and to methods of beneficially regulating gastrointestinal motility comprising administration of a therapeutically effective among of one of the compounds. Also provided are pharmaceutical composition comprising a compound of formula I and a pharmaceutically acceptable carrier.

    摘要翻译： 提供了相对于某些所需胰淀素活性作为胰岛淀粉样多肽激动剂的相应于某些所需降钙素活性的作为降钙素激动剂的式I化合物。 这些化合物可用于治疗哺乳动物的燃料代谢紊乱，包括但不限于糖尿病，包括I型糖尿病和II型糖尿病。 本发明还涉及治疗I型糖尿病，治疗II型糖尿病的方法和有益地调节胃肠运动的方法，包括给予一种化合物中治疗有效的方法。 还提供了包含式I化合物和药学上可接受的载体的药物组合物。